Want to see KNSA full AI Analyst Report?

Kiniksa Pharmaceuticals (KNSA) Revenue

606 Followers

Kiniksa Pharmaceuticals Revenue

Kiniksa Pharmaceuticals had a revenue of 243.60M in the quarter ending Jun 30, 2026, with 13.69%. This bring the company's revenue in the last twelve months to 840.85M, Decreased 11.51%. In the fiscal year ending Dec 31, 2025, Kiniksa Pharmaceuticals had annual revenue of 677.56M with 60.09% growth.

Revenue (ttm)

840.85M

Revenue Growth

58.85%

P/S Ratio

8.82

Revenue/Employee

$1,851,268

Employees

366

Market Cap

$5.98B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	677.56M	254.32M	+60.09%
Dec 31, 2024	423.24M	152.98M	+56.60%
Dec 31, 2023	270.26M	50.08M	+22.74%
Dec 31, 2022	220.18M	181.64M	+471.24%
Dec 31, 2021	38.54M	―	+∞%
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―